EconPapers    
Economics at your fingertips  
 

Details about Frank Lichtenberg

E-mail:
Homepage:http://www8.gsb.columbia.edu/cbs-directory/detail/frl1
Phone:(212) 854-4408
Postal address:Courtney C. Brown Professor of Business Columbia University 504 Uris Hall 3022 Broadway New York, NY 10027
Workplace:Finance and Economics Department, Graduate School of Business, Columbia University, (more information at EDIRC)
National Bureau of Economic Research (NBER), (more information at EDIRC)
CESifo, (more information at EDIRC)

Access statistics for papers by Frank Lichtenberg.

Last updated 2017-11-16. Update your information in the RePEc Author Service.

Short-id: pli76


Jump to Journal Articles Chapters

Working Papers

2017

  1. How Cost-Effective Are New Cancer Drugs in the U.S.?
    CESifo Working Paper Series, CESifo Group Munich Downloads
  2. The Impact of Public and Private Research Support on Premature Cancer Mortality and Hospitalization in the U.S., 1999-2013
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads

2015

  1. Listen to your Doctor, or else!: Medication Under-use and Overuse and Long-term Health Outcomes of Danish Diabetes Patients
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
  2. Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010
    CESifo Working Paper Series, CESifo Group Munich Downloads
    See also Journal Article in International Journal of the Economics of Business (2015)
  3. The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (3)
    See also Journal Article in International Journal of Health Economics and Management (2015)

2013

  1. The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
  2. The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence
    CESifo Working Paper Series, CESifo Group Munich Downloads
    See also Journal Article in Social Science & Medicine (2015)

2012

  1. Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (1)
  2. The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (4)
    See also Journal Article in Forum for Health Economics & Policy (2013)
  3. The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
  4. The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data
    CESifo Working Paper Series, CESifo Group Munich Downloads View citations (1)
    See also Journal Article in Economics of Innovation and New Technology (2014)

2011

  1. The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
    See also Journal Article in Social Science & Medicine (2013)

2010

  1. Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A reexamination using data from the U.S. and Australia
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (1)
    See also Journal Article in Forum for Health Economics & Policy (2010)
  2. Has medical innovation reduced cancer mortality?
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (3)
    See also Journal Article in CESifo Economic Studies (2014)
  3. Impact of Specialization on Health Outcomes – Evidence from U.S. Cancer Data
    SOI - Working Papers, Socioeconomic Institute - University of Zurich Downloads
  4. The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France
    CESifo Working Paper Series, CESifo Group Munich Downloads View citations (1)

2009

  1. Response to Baker and Fugh-Berman's Critique of my Paper, "Why has Longevity Increased more in some States than in others?"
    CESifo Working Paper Series, CESifo Group Munich Downloads
  2. Spurious correlation in estimation of the health production function: A note
    SOI - Working Papers, Socioeconomic Institute - University of Zurich Downloads View citations (4)
    See also Journal Article in Economics Bulletin (2010)
  3. The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (8)
    See also Journal Article in International Journal of Health Economics and Management (2011)

2008

  1. Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (2)
    See also Journal Article in Health Economics (2009)
  2. Pharmaceutical innovation and the longevity of Australians: a first look
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (8)

2006

  1. Importation and Innovation
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (3)
    See also Journal Article in Economics of Innovation and New Technology (2007)
  2. The Impact of Increased Utilization of HIV Drugs on Longevity and Medical Expenditures: An Assessment Based on Aggregate U.S. Time-Series Data
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (6)
  3. The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads

2004

  1. The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (1)
  2. The Expanding Pharmaceutical Arsenal in the War on Cancer
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (10)
    Also in 2004 Meeting Papers, Society for Economic Dynamics (2004) Downloads View citations (9)

2003

  1. Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (21)
  2. The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (8)
    See also Journal Article in International Journal of Health Economics and Management (2005)

2002

  1. Benefits and Costs of Newer Drugs: An Update
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (8)
    See also Journal Article in Managerial and Decision Economics (2007)
  2. Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health"
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (7)
    See also Journal Article in Managerial and Decision Economics (2007)
  3. Sources of U.S. Longevity Increase, 1960-1997
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (9)
    Also in CESifo Working Paper Series, CESifo Group Munich (2000) Downloads View citations (1)
  4. The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (13)
    See also Journal Article in Journal of Law and Economics (2002)
  5. The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the US
    Working Papers, Harris School of Public Policy Studies, University of Chicago Downloads
  6. The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (3)
  7. The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (27)
  8. Using Patents Data to Map Technical Change in Health-Related Areas
    OECD Science, Technology and Industry Working Papers, OECD Publishing Downloads View citations (1)

2001

  1. Does foreign direct investment transfer technology across borders?
    ULB Institutional Repository, ULB -- Universite Libre de Bruxelles View citations (126)
    See also Journal Article in The Review of Economics and Statistics (2001)
  2. The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (4)
    Also in CESifo Working Paper Series, CESifo Group Munich (2000) Downloads
  3. The Effect of New Drugs on Mortality from Rare Diseases and HIV
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (2)

2000

  1. The Impact of Hospital Quality-Related Practices on Health Outcomes
    Center for Policy Research Working Papers, Center for Policy Research, Maxwell School, Syracuse University Downloads

1998

  1. International R&D spillovers comment
    ULB Institutional Repository, ULB -- Universite Libre de Bruxelles Downloads View citations (47)
    See also Journal Article in European Economic Review (1998)
  2. Pharmaceutical Innovation, Mortality Reduction, and Economic Growth
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (17)
  3. The Allocation of Publicly-Funded Biomedical Research
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (4)
    Also in CESifo Working Paper Series, CESifo Group Munich (1997) Downloads

    See also Chapter (2001)

1997

  1. The Impact and Organization of Publicly-Funded Research and Development in the European Community
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (13)
    See also Journal Article in Annals of Economics and Statistics (1998)

1996

  1. Computer Use and Productivity Growth in Federal Government Agencies, 1987 to 1992
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (1)
  2. Computer Use and Productivity Growth in federal Government Agencies
    Working Papers, Columbia - Graduate School of Business View citations (3)
  3. International R&D Spillovers: A Re-Examination
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (42)
  4. The Effect of New Political Administration on Federal Government Productivity and Employment
    Working Papers, Columbia - Graduate School of Business View citations (1)
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1996) Downloads View citations (1)
  5. The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (9)
  6. The European Strategic Program for Research in Information Technologie (ESPRIT): An Ex-Post Analysis
    Working Papers, Columbia - Graduate School of Business View citations (1)

1993

  1. The Output Contributions of Computer Equipment and Personnel: A Firm- Level Analysis
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (49)

1992

  1. Ownership Structure and Corporate Performance in Japan
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (39)
    See also Journal Article in Japan and the World Economy (1994)
  2. R&D Investment and International Productivity Differences
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (69)

1991

  1. Labor Market Institutions, Liquidity Constraints, and Macroeconomic Stability
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
    See also Journal Article in Journal of Economic Behavior & Organization (1995)

1990

  1. Industrial De-Diversification and Its Consequences for Productivity
    Economics Working Paper Archive, Levy Economics Institute Downloads View citations (2)
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1990) Downloads View citations (31)

    See also Journal Article in Journal of Economic Behavior & Organization (1992)

1989

  1. How Elastic is the Government's Demand for Weapons?
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (4)
    Also in Working Papers, Columbia - Graduate School of Business (1988)

    See also Journal Article in Journal of Public Economics (1989)
  2. THE EFFECT OF TAKEOVERS ON THE EMPLOYMENT AND WAGES OF CENTRAL-OFFICE AND OTHER PERSONNEL
    Working Papers, Columbia - Graduate School of Business View citations (3)
    Also in Working Papers, U.S. Census Bureau, Center for Economic Studies (1989) Downloads View citations (3)
    NBER Working Papers, National Bureau of Economic Research, Inc (1989) Downloads View citations (9)
  3. The Effects Of Leveraged Buyouts On Productivity And Related Aspects Of Firm Behavior
    Working Papers, U.S. Census Bureau, Center for Economic Studies Downloads View citations (4)
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1989) Downloads View citations (86)

    See also Journal Article in Journal of Financial Economics (1990)
  4. The Effects of Mergers on Prices, Costs, And Capacity Utilization in the U.S. Air Transportation Industry, 1970-84
    Economics Working Paper Archive, Levy Economics Institute Downloads
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1989) Downloads
  5. The Impact of R&D Investment On Productivity - New Evidence Using Linked R&D-LRD Data
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (63)
    See also Journal Article in Economic Inquiry (1991)
  6. USING LINKED CENSUS R&D-LRD DATA TO ANALYZE THE EFFECT OF R&D INVESTMENT ON TOTAL FACTOR PRODUCTIVITY GROWTH
    Working Papers, U.S. Census Bureau, Center for Economic Studies Downloads View citations (5)

1988

  1. CONTRIBUTIONS TO FEDERAL ELECTION CAMPAIGNS BY GOVERNMENT CONTRACTORS
    Working Papers, Columbia - Graduate School of Business
    See also Journal Article in Journal of Industrial Economics (1989)
  2. CROWDING OUT: THE IMPACT OF THE STRATEGIC DEFENSE INITIATIVE ON U.S. CIVILIAN R&D INVESTMENT AND INDUSTRIAL COMPETITIVENESS
    Working Papers, Columbia - Graduate School of Business
  3. GOVERNMENT SUBSIDIES TO PRIVATE MILITARY R&D INVESTMEN: DOD'S IR&D POLICY
    Working Papers, Columbia - Graduate School of Business View citations (3)
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (1988) Downloads View citations (1)
  4. IR&D Project Data and Theories of R&D Investment
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
  5. Technical Change, Learning, and Wages
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (5)

1986

  1. Errors of Measurement in Output Deflators
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (14)
    See also Journal Article in Journal of Business & Economic Statistics (1989)
  2. Private Investment in R&D to Signal Ability to Perform Government Contracts
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (2)

1985

  1. The Comparative Advantage of Educated Workers in Implementing New Technology: Some Empirical Evidence
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (4)

1982

  1. R and D and Productivity at the Industry Level: Is There Still a Relationship?
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (4)

1981

  1. Training, Tenure, and Productivity
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads

Journal Articles

2017

  1. The Impact of Pharmaceutical Innovation on Cancer Mortality in Belgium, 2004–2012
    Forum for Health Economics & Policy, 2017, 20, (1), 28 Downloads
  2. The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013
    Latin American Economic Review, 2017, 26, (1), 1-22 Downloads

2016

  1. The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012
    The European Journal of Health Economics, 2016, 17, (7), 833-854 Downloads View citations (2)

2015

  1. Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010
    International Journal of the Economics of Business, 2015, 22, (2), 277-299 Downloads
    See also Working Paper (2015)
  2. The Impact of Pharmaceutical Innovation on Premature Mortality, Cancer Mortality, and Hospitalization in Slovenia, 1997–2010
    Applied Health Economics and Health Policy, 2015, 13, (2), 207-222 Downloads
  3. The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011
    International Journal of Health Economics and Management, 2015, 15, (3), 339-359 Downloads View citations (3)
    See also Working Paper (2015)
  4. The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence
    Social Science & Medicine, 2015, 130, (C), 162-171 Downloads
    See also Working Paper (2013)

2014

  1. Has Medical Innovation Reduced Cancer Mortality?
    CESifo Economic Studies, 2014, 60, (1), 135-177 Downloads View citations (8)
    See also Working Paper (2010)
  2. The Impact of Pharmaceutical Innovation on Disability Days and the Use of Medical Services in the United States, 1997-2010
    Journal of Human Capital, 2014, 8, (4), 432 - 480 Downloads
  3. The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010
    Health Policy, 2014, 117, (3), 361-373 Downloads View citations (2)
  4. The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009
    Economics & Human Biology, 2014, 13, (C), 107-127 Downloads View citations (4)
  5. The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data
    Economics of Innovation and New Technology, 2014, 23, (3), 239-273 Downloads
    See also Working Paper (2012)

2013

  1. The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files
    Forum for Health Economics & Policy, 2013, 16, (1), 1-33 Downloads View citations (4)
    See also Working Paper (2012)
  2. The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999–2007
    The European Journal of Health Economics, 2013, 14, (1), 41-56 Downloads View citations (1)
  3. The impact of therapeutic procedure innovation on hospital patient longevity: Evidence from Western Australia, 2000–2007
    Social Science & Medicine, 2013, 77, (C), 50-59 Downloads View citations (3)
    See also Working Paper (2011)

2012

  1. Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7
    PharmacoEconomics, 2012, 30, (3), 197-211 Downloads View citations (6)
  2. Does competition stimulate drug utilization? The impact of changes in market structure on US drug prices, marketing and utilization
    International Review of Law and Economics, 2012, 32, (1), 95-109 Downloads View citations (2)

2011

  1. Has Pharmaceutical Innovation Reduced Social Security Disability Growth?
    International Journal of the Economics of Business, 2011, 18, (2), 293-316 Downloads
  2. The quality of medical care, behavioral risk factors, and longevity growth
    International Journal of Health Economics and Management, 2011, 11, (1), 1-34 Downloads View citations (6)
    See also Working Paper (2009)

2010

  1. Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia
    Forum for Health Economics & Policy, 2010, 13, (2), 1-18 Downloads View citations (1)
    See also Working Paper (2010)
  2. Pharmaceutical Price Discrimination and Social Welfare
    Capitalism and Society, 2010, 5, (1), 1-32 Downloads View citations (5)
  3. Pharmaceutical innovation and mortality in the United States, 1960-2000. A commentary on Schnittker and Karandinos
    Social Science & Medicine, 2010, 70, (7), 969-971 Downloads
  4. Spurious correlation in estimation of the health production function: A note
    Economics Bulletin, 2010, 30, (3), 2505-2514 Downloads View citations (2)
    See also Working Paper (2009)

2009

  1. Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data on 20 OECD countries, 1995-2003
    Health Economics, 2009, 18, (5), 519-534 Downloads
    See also Working Paper (2008)
  2. The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004
    Economics of Innovation and New Technology, 2009, 18, (5), 407-428 Downloads View citations (5)

2008

  1. Pharmaceutical Innovation and U.S. Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data
    Forum for Health Economics & Policy, 2008, 10, (1), 1-27 Downloads View citations (2)

2007

  1. Benefits and costs of newer drugs: an update
    Managerial and Decision Economics, 2007, 28, (4-5), 485-490 Downloads View citations (1)
    See also Working Paper (2002)
  2. IMPORTATION AND INNOVATION
    Economics of Innovation and New Technology, 2007, 16, (6), 403-417 Downloads
    See also Working Paper (2006)
  3. Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as 'Equipment for Your Health'
    Managerial and Decision Economics, 2007, 28, (4-5), 371-392 Downloads View citations (4)
    See also Working Paper (2002)
  4. The Impact of New Drugs on US Longevity and Medical Expenditure, 1990–2003: Evidence from Longitudinal, Disease-Level Data
    American Economic Review, 2007, 97, (2), 438-443 Downloads View citations (9)

2006

  1. Has Using Newer Drugs Reduced Admissions to Hospitals and Nursing Homes?
    Swiss Journal of Economics and Statistics (SJES), 2006, 142, (V), 69-75 Downloads
  2. The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003
    PharmacoEconomics, 2006, 24, (3), 5-25 Downloads View citations (5)

2005

  1. Are the More Educated More Likely to Use New Drugs?
    Annals of Economics and Statistics, 2005, (79-80), 671-696 Downloads View citations (1)
    See also Chapter (2010)
  2. The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001
    International Journal of Health Economics and Management, 2005, 5, (1), 47-73 Downloads View citations (12)
    See also Working Paper (2003)

2004

  1. Sources of U.S. longevity increase, 1960-2001
    The Quarterly Review of Economics and Finance, 2004, 44, (3), 369-389 Downloads View citations (14)

2003

  1. The benefits to society of new drugs: a survey of the econometric evidence
    Proceedings, 2003, (Sep), 43-59 Downloads View citations (2)
  2. The effect of new drug approvals on HIV mortality in the US, 1987-1998
    Economics & Human Biology, 2003, 1, (2), 259-266 Downloads View citations (1)

2002

  1. The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry
    Journal of Law and Economics, 2002, 45, (S2), 643-672 Downloads View citations (8)
    See also Working Paper (2002)
  2. The Effects of Medicare on Health Care Utilization and Outcomes
    Forum for Health Economics & Policy, 2002, 5, (1), 1-29 Downloads View citations (22)
    See also Chapter (2002)

2001

  1. Does Foreign Direct Investment Transfer Technology Across Borders?
    The Review of Economics and Statistics, 2001, 83, (3), 490-497 Downloads View citations (185)
    See also Working Paper (2001)

1999

  1. Information technology and its impact on firm-level productivity: evidence from government and private data sources, 1977-1993
    Canadian Journal of Economics, 1999, 32, (2), 335-362 Downloads View citations (35)
  2. Managerial ownership and firm performance: A re-examination using productivity measurement
    Journal of Corporate Finance, 1999, 5, (4), 323-339 Downloads View citations (26)

1998

  1. Computer Use and Productivity Growth in US Federal Government Agencies, 1987-92
    Journal of Industrial Economics, 1998, 46, (2), 257-79 Downloads View citations (11)
  2. International R&D spillovers: A comment
    European Economic Review, 1998, 42, (8), 1483-1491 Downloads View citations (124)
    See also Working Paper (1998)
  3. The Impact and Organization of Publicly-Funded Research and development in the European Community
    Annals of Economics and Statistics, 1998, (49-50), 199-222 Downloads View citations (8)
    See also Working Paper (1997)

1996

  1. Book Reviews
    Journal of Economics, 1996, 63, (3), 325-345 Downloads
  2. Do (More and Better) Drugs Keep People Out of Hospitals?
    American Economic Review, 1996, 86, (2), 384-88 Downloads View citations (30)

1995

  1. Labour market institutions, liquidity constraints, and macroeconomic stability
    Journal of Economic Behavior & Organization, 1995, 28, (1), 145-154 Downloads
    See also Working Paper (1991)
  2. Rejoinder to comment by Maarten Vendrik
    Journal of Economic Behavior & Organization, 1995, 28, (3), 455-456 Downloads

1994

  1. Ownership structure and corporate performance in Japan
    Japan and the World Economy, 1994, 6, (3), 239-261 Downloads View citations (7)
    See also Working Paper (1992)
  2. Testing the Convergence Hypothesis
    The Review of Economics and Statistics, 1994, 76, (3), 576-79 Downloads View citations (57)

1992

  1. Industrial de-diversification and its consequences for productivity
    Journal of Economic Behavior & Organization, 1992, 18, (3), 427-438 Downloads View citations (14)
    See also Working Paper (1990)

1991

  1. The Impact of R&D Investment on Productivity--New Evidence Using Linked R&D-LRD Data
    Economic Inquiry, 1991, 29, (2), 203-29 View citations (40)
    See also Working Paper (1989)
  2. The Managerial Response to Regulation of Financial Reporting for Segments of a Business Enterprise
    Journal of Regulatory Economics, 1991, 3, (3), 241-49 View citations (12)

1990

  1. Issues in measuring industrial R&D
    Research Policy, 1990, 19, (2), 157-163 Downloads View citations (3)
  2. The Effect of Ownership Changes on the Employment and Wages of Central Office and Other Personnel
    Journal of Law and Economics, 1990, 33, (2), 383-408 Downloads View citations (43)
  3. The effects of leveraged buyouts on productivity and related aspects of firm behavior
    Journal of Financial Economics, 1990, 27, (1), 165-194 Downloads View citations (41)
    See also Working Paper (1989)

1989

  1. Contributions to Federal Election Campaigns by Government Contractors
    Journal of Industrial Economics, 1989, 38, (1), 31-48 Downloads View citations (2)
    See also Working Paper (1988)
  2. Errors of Measurement in Output Deflators
    Journal of Business & Economic Statistics, 1989, 7, (1), 1-9 View citations (14)
    See also Working Paper (1986)
  3. How elastic is the government's demand for weapons?
    Journal of Public Economics, 1989, 40, (1), 57-78 Downloads View citations (2)
    See also Working Paper (1989)
  4. IR & D project data and theories of R & D investment
    Journal of Economic Dynamics and Control, 1989, 13, (2), 271-282 Downloads View citations (1)
  5. THE EFFECT OF CONTROL CHANGES ON THE PRODUCTIVITY OF U.S. MANUFACTURING PLANTS
    Journal of Applied Corporate Finance, 1989, 2, (2), 60-67 Downloads View citations (3)

1988

  1. Estimation of the Internal Adjustment Costs Model Using Longitudinal Establishment Data
    The Review of Economics and Statistics, 1988, 70, (3), 421-30 Downloads View citations (20)
  2. The Private R&D Investment Response to Federal Design and Technical Competitions
    American Economic Review, 1988, 78, (3), 550-59 Downloads View citations (46)
  3. The burden of government:, Stanford: Hoover Institution Press, 1986. x + 188 pp., $23.95
    Journal of Comparative Economics, 1988, 12, (2), 304-305 Downloads

1987

  1. Changing market opportunities and the structure of R & D investment: The case of energy
    Energy Economics, 1987, 9, (3), 154-158 Downloads View citations (1)
  2. Productivity and Changes in Ownership of Manufactoring Plants
    Brookings Papers on Economic Activity, 1987, 18, (3), 643-684 Downloads View citations (75)
  3. The Comparative Advantage of Educated Workers in Implementing New Technology
    The Review of Economics and Statistics, 1987, 69, (1), 1-11 Downloads View citations (338)
  4. The Effect of Government Funding on Private Industrial Research and Development: A Re-assessment
    Journal of Industrial Economics, 1987, 36, (1), 97-104 Downloads View citations (35)

1986

  1. Energy prices and induced innovation
    Research Policy, 1986, 15, (2), 67-75 Downloads View citations (16)

1984

  1. Interindustry Technology Flows and Productivity Growth: A Re-examination
    The Review of Economics and Statistics, 1984, 66, (2), 324-29 Downloads View citations (90)
  2. The Relationship between Federal Contract R&D and Company R&D
    American Economic Review, 1984, 74, (2), 73-78 View citations (40)

Chapters

2017

  1. The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy following a Major Cardiovascular Event: Evidence from Geisinger
    A chapter in Economic Dimensions of Personalized and Precision Medicine, 2017 Downloads

2016

  1. The Impact of Biomedical Research on U.S. Cancer Mortality: A Bibliometric Analysis
    A chapter in Measuring and Modeling Health Care Costs, 2016 Downloads

2010

  1. Are the More Educated More LIkely to Use New Drugs?
    A chapter in Contributions in Memory of Zvi Griliches, 2010, pp 671-696 View citations (1)
    See also Journal Article in Annals of Economics and Statistics (2005)

2005

  1. Pharmaceutical Knowledge-Capital Accumulation and Longevity
    A chapter in Measuring Capital in the New Economy, 2005, pp 237-274 Downloads View citations (5)

2002

  1. The Effects of Medicare on Health Care Utilization and Outcomes
    A chapter in Frontiers in Health Policy Research, Volume 5, 2002, pp 27-52 Downloads View citations (19)
    See also Journal Article in Forum for Health Economics & Policy (2002)

2001

  1. The Allocation of Publicly Funded Biomedical Research
    A chapter in Medical Care Output and Productivity, 2001, pp 565-590 Downloads View citations (4)
    See also Working Paper (1998)

1995

  1. Economics of defense R&D
    Chapter 15 in Handbook of Defense Economics, 1995, vol. 1, pp 431-457 Downloads View citations (8)

1984

  1. R&D and Productivity Growth at the Industry Level: Is There Still a Relationship?
    A chapter in R&D, Patents, and Productivity, 1984, pp 465-502 Downloads View citations (50)
 
Page updated 2017-12-16